Most Recent Articles by Jody A. Charnow
Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.
Study results support the role of androgens and benefits of 5-alpha-reductase inhibition in the progression of bladder cancer.
In an analysis of data from the SEER program, researchers determined that early detection of prostate cancer has let to an improvement in the number of men presenting with metastatic prostate cancer.
Finasteride recipients had a 21.1% decreased risk of prostate cancer compared with placebo recipients, researchers found.
ADT recipients reported worse subjective sleep disturbance, researchers found.
More Articles by Jody A. Charnow
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Prognostic Factors for Survival Among Patients With Primary Bone Sarcomas of Small Bones
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- A Call for More Tailored Cancer Education Programs to Improve Screening
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|